SCHEMBL30400148

SCHEMBL30400148

CN1CCN(c2ccc(NC(=O)c3cnc4[nH]cc(-c5cc6ccncc6s5)c4c3)cn2)CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 10/20 0.48
▸ CLK1 P49759 4/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ DYRK1B Q9Y463 1/20 0.42
▸ HDAC2 Q92769 2/20 0.41
▸ PDE7A Q13946 1/20 0.41
▸ GSK3B P49841 2/20 0.41
▸ WNT1 P04628 2/20 0.41
▸ PPARG P37231 1/20 0.40
▸ IL2 P60568 1/20 0.40
▸ MAP4K1 Q92918 1/20 0.40
▸ CLK2 P49760 2/20 0.39
▸ CLK3 P49761 2/20 0.39
▸ TDO2 P48775 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26175197 1.00 DYRK1A (0.48) DYRK1ACLK1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL30400402 0.83 MAP4K1 (0.58) DYRK1ACLK1IL2MAP4K1TDO2
SCHEMBL26175600 0.83 MAP4K1 (0.58) DYRK1ACLK1IL2MAP4K1TDO2
SCHEMBL26174957 0.82 MAP3K11 (0.49) DYRK1ACLK1
SCHEMBL26175116 0.81 MAPK7 (0.45) DYRK1ACLK1DYRK1BGSK3BWNT1
SCHEMBL26174909 0.81 HPGDS (0.41) DYRK1ADYRK1BWNT1
SCHEMBL26175220 0.81 RAB9A (0.56) DYRK1ACLK1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL30400764 0.81 RAB9A (0.56) DYRK1ACLK1RAB9AL3MBTL1SMN1; SMN2
SCHEMBL30399189 0.79 DYRK1A (0.47) DYRK1ACLK1DYRK1BIL2MAP4K1
SCHEMBL26177407 0.79 DYRK1A (0.47) DYRK1ACLK1DYRK1BIL2MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4415817-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BioSplice Therapeutics, Inc. (US) 2024-08-21 — — EP claimed
WO-2023064349-A1 1H-PYRROLO[2,3-B]PYRIDINES AS DYRK1A INHIBITORS BIOSPLICE THERAPEUTICS, INC. (US) 2023-04-20 — — WO claimed
Send feedback